Stockreport

Oppenheimer Upgrade Fuels Relay Therapeutics Rally On Zovegalisib Optimism [Seeking Alpha]

Celcuity Inc.  (CELC) 
Last celcuity inc. earnings: 3/12 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: celcuity.com/home/investors
PDF Zovegalisib's mutant-selective PI3Ka inhibition offers a differentiated safety and efficacy profile versus broader PI3K inhibitors, targeting a large, underserved patie [Read more]